Nanocapsules: a novel lipid formulation platform for platinum-based anti-cancer drugs.
Platinum-based anti-cancer agents have been used for many years to treat many different types of cancer. However, the efficacy of these drugs is limited by serious side effects. One of the strategies to reduce the side effects is encapsulation of the drug in a lipid formulation. Recently, we discovered a novel method for the efficient encapsulation of cisplatin in a lipid formulation. The method is unique in that it does not generate conventional liposomes but nanocapsules: small aggregates of solid cisplatin covered by a lipid bilayer. Also carboplatin, a cisplatin-derived anti-cancer drug with different chemical properties, can be efficiently encapsulated by a similar method. The encapsulation in nanocapsules dramatically improves the in vitro cytotoxicity of the platinum drugs. Our results hold the promise that the nanocapsule technology could prove successful in the efficient encapsulation of many other (platinum-based) drugs, and thereby improve their therapeutic index and profile in vivo.
Hamelers
Irene H L
IH
Department Biochemistry of Membranes, Bijvoet Institute and Institute of Biomembranes, Utrecht University, Padualaan, Utrecht, The Netherlands. i.h.l.hamelers@chem.uu.nl
de Kroon
Anton I P M
AI
D000970:Antineoplastic Agents / Q000737:chemistry*; D016190:Carboplatin / Q000737:chemistry*; D002626:Chemistry, Pharmaceutical; D002945:Cisplatin / Q000737:chemistry*; D006801:Humans; D008055:Lipids / Q000737:chemistry*; D053769:Nanocapsules
D000970:Antineoplastic Agents; D008055:Lipids; D053769:Nanocapsules; D016190:Carboplatin; D002945:Cisplatin